These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10571246)

  • 41. Modulation of protein kinase C in antitumor treatment.
    Hofmann J
    Rev Physiol Biochem Pharmacol; 2001; 142():1-96. PubMed ID: 11190577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
    J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance.
    Perez-Victorias FJ; Conseil G; Munoz-Martinez F; Perez-Victoria JM; Dayan G; Marsaud V; Castanys S; Gamarro F; Renoir JM; Di Pietro A
    Cell Mol Life Sci; 2003 Mar; 60(3):526-35. PubMed ID: 12737312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
    Chambers TC; Zheng B; Kuo JF
    Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacterial expression of the linker region of human MDR1 P-glycoprotein and mutational analysis of phosphorylation sites.
    Chambers TC; Germann UA; Gottesman MM; Pastan I; Kuo JF; Ambudkar SV
    Biochemistry; 1995 Oct; 34(43):14156-62. PubMed ID: 7578013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Staal RG; Yang JM; Hait WN; Sonsalla PK
    Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
    Ruth A; Stein WD; Rose E; Roninson IB
    Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W; Sharif TR; Houghton PJ; Sharif M
    Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective inhibition of the effects of phorbol ester on doxorubicin resistance and P-glycoprotein by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) in multidrug-resistant MCF-7/Dox human breast carcinoma cells.
    Ahn CH; Kong JY; Choi WC; Hwang MS
    Biochem Pharmacol; 1996 Aug; 52(3):393-9. PubMed ID: 8687492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.
    Budworth J; Gant TW; Gescher A
    Br J Cancer; 1997; 75(9):1330-5. PubMed ID: 9155054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of prenylcysteines that interact with P-glycoprotein and inhibit drug transport in tumor cells.
    Zhang L; Sachs CW; Fu HW; Fine RL; Casey PJ
    J Biol Chem; 1995 Sep; 270(39):22859-65. PubMed ID: 7559420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P-glycoprotein substrates and antagonists cluster into two distinct groups.
    Scala S; Akhmed N; Rao US; Paull K; Lan LB; Dickstein B; Lee JS; Elgemeie GH; Stein WD; Bates SE
    Mol Pharmacol; 1997 Jun; 51(6):1024-33. PubMed ID: 9187269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
    Pallis M; Turzanski J; Higashi Y; Russell N
    Leuk Lymphoma; 2002 Jun; 43(6):1221-8. PubMed ID: 12152989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase C regulation of p-glycoprotein-mediated xenobiotic secretion in renal proximal tubule.
    Miller DS; Sussman CR; Renfro JL
    Am J Physiol; 1998 Nov; 275(5):F785-95. PubMed ID: 9815136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
    Sharom FJ; Lu P; Liu R; Yu X
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Function of P-glycoprotein expressed in placenta and mole.
    Nakamura Y; Ikeda S; Furukawa T; Sumizawa T; Tani A; Akiyama S; Nagata Y
    Biochem Biophys Res Commun; 1997 Jun; 235(3):849-53. PubMed ID: 9207250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid hormones inhibit binding of Vinca alkaloid to multidrug resistance related P-glycoprotein.
    Naito M; Yusa K; Tsuruo T
    Biochem Biophys Res Commun; 1989 Feb; 158(3):1066-71. PubMed ID: 2563940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells.
    Sato W; Yusa K; Naito M; Tsuruo T
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1252-7. PubMed ID: 1980066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.